Maximize Your Impact At CPHI Korea 2025
CPHI Korea 2025, taking place on August 26 at COEX Convention & Exhibition Center in Seoul, brings together key decision-makers across South Korea’s pharmaceutical, biopharma, and life sciences sectors. This event is a strategic entry point into one of Asia’s most technologically advanced health markets, with attendees representing companies involved in APIs, finished dosage, packaging, machinery, and contract services.
With senior buyers and regulatory stakeholders in attendance, this forum is highly focused on sourcing partnerships, finalizing supply chain agreements, and evaluating new contract manufacturing relationships. Attendees often lead procurement for Korea’s fast-growing generic markets and biomedical innovation initiatives. Using the Vendelux enriched conference attendee list, companies can pinpoint buyers by function, funding stage, or commercial interests and begin outreach in advance of the show. The contact-level intelligence gives commercial and partnership teams visibility into where decisions are being made—long before doors open in Seoul.
How Sales, Marketing and Revops Teams Can Use This Attendee List
Sales and marketing teams targeting the pharmaceutical and biomanufacturing sectors can use the enriched conference attendee list to identify key procurement leads, R&D heads, and business development executives attending CPHI Korea 2025. Attendee data enables segmentation based on company type—such as CDMOs, ingredient providers, or formulation labs—so outreach reflects the prospect’s role in the pharma pipeline.
Rather than generic event follow-ups, teams can tie messaging to production timelines, ingredient sourcing goals, or market entry strategies discussed during the event. Booking early meetings with verified budget holders is essential, as vendor evaluation often begins weeks prior to the show. Vendelux’s enriched data—featuring job roles, specialties, and verified contact information—helps align each message with the buyer’s commercial focus. Use this context-rich view to facilitate in-depth conversations that convert on-site connections into longer-term supplier agreements or go-to-market alliances.
Timing Is Everything
CPHI Korea 2025 takes place on August 26, 2025. With just under three months to go, early-stage engagement is key to securing meetings with decision-makers finalizing budgets before Q4. Buyers attending this event are evaluating contract relationships and supplier partnerships now.
Vendelux gives teams early access to attendee data so sales and marketing can match outreach to relevant buyer types and prioritize accounts already entering sourcing cycles. By aligning campaigns with confirmed attendee profiles before the event, teams increase the likelihood of pre-scheduled conversations and build familiarity ahead of face-to-face connections in Seoul.
What’s Included In The CPHI Korea 2025 Attendee List?
Vendelux provides visibility into executives expected to attend CPHI Korea 2025 through a combination of organizer-supplied data and predictive insights. Clients are able to upload a list of target accounts to identify matches in the attendee file. The enriched list includes first and last names, job titles, company names, company websites, city, state, country, LinkedIn profiles, verified email addresses, and phone numbers when available.
Where Is CPHI Korea 2025?
The event is taking place at COEX Convention & Exhibition Center in Seoul, South Korea.
When Is CPHI Korea 2025?
CPHI Korea 2025 is scheduled for August 26, 2025.
What Type Of Event Is CPHI Korea 2025?
CPHI Korea 2025 is a pharmaceutical industry event focused on ingredients, contract development, manufacturing, and regulatory partnerships. It includes an exhibition, technical presentations, business matchmaking opportunities, and panel discussions that facilitate direct conversations between suppliers and buyers in the pharma and biotech sectors.
How Many People Attend CPHI Korea 2025?
CPHI Korea 2025 is expected to attract over 6,000 attendees from more than 40 countries. The audience includes senior professionals in supply chain management, regulatory affairs, business development, and R&D across pharmaceutical manufacturing and biotechnology firms.
